Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kaas
    Member
    • Dec 2012
    • 20

    #1

    CPM in EdgeR - before and after exactTest

    I have normalized my RNAseq read counts in EdgeR. If I try to look at the normalized data:

    total=cpm(w, normalized.lib.size=TRUE)

    And specifically the CPM values for my cell line 1 (in triplicates) for the gene Hspa5

    total["Hspa5",1:3]
    7492.944 6750.397 5727.190

    If I find the fold change between cell line 1 and my control cell line 2 I get:

    total["Hspa5",1:3]/total["Hspa5",27:29]
    3.409239 3.399253 2.910913

    So by this very basic test I find that a fold change of about 3.3 fold is found between my two cell lines

    Then I use EdgeR to find the same
    et <- exactTest(w, pair=c(13,1))
    et["Hspa5",]
    logFC logCPM PValue FDR
    Hspa5 1.80454 12.11638 2.519341e-65 4.262793e-63

    FC = exp(1.80454) = 6.077175
    CPM = exp(12.11638) = 182842

    So after EdgeR has made the comparison the CPM value is suddenly 27x higher and (more importantly for me) the fold change is 2x higher. Is there someone out there that can explain this difference for me?

    I have read this thread (http://seqanswers.com/forums/showthread.php?t=23722) stating that log(CPM) is actually taking into account the estimated dispersions and the library sizes... but 27x difference? and why the 2x difference in the fold change?

    Which of the 2 results would you state in a table showing your RNAseq results in a publication?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...